These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 35277915)
1. HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer. Xia N; Yang N; Shan Q; Wang Z; Liu X; Chen Y; Lu J; Huang W; Wang Z J Cell Mol Med; 2022 Apr; 26(8):2322-2336. PubMed ID: 35277915 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4. Park YM; Hwang SJ; Masuda K; Choi KM; Jeong MR; Nam DH; Gorospe M; Kim HH Mol Cell Biol; 2012 Oct; 32(20):4237-44. PubMed ID: 22907752 [TBL] [Abstract][Full Text] [Related]
3. hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3. Yang N; Liu L; Liu X; Chen Y; Lu J; Wang Z Biomed Res Int; 2022; 2022():6319685. PubMed ID: 35355828 [TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer. Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888 [TBL] [Abstract][Full Text] [Related]
5. HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression. Liu D; Luo X; Xie M; Zhang T; Chen X; Zhang B; Sun M; Wang Y; Feng Y; Ji X; Li Y; Liu B; Huang W; Xia L Cancer Sci; 2022 Oct; 113(10):3347-3361. PubMed ID: 35848884 [TBL] [Abstract][Full Text] [Related]
6. DUSP3 modulates IRES-dependent translation of mRNAs through dephosphorylation of the HNRNPC protein in cells under genotoxic stimulus. Ferruzo PYM; Boell VK; Russo LC; Oliveira CC; Forti FL Biol Cell; 2024 May; 116(5):e2300128. PubMed ID: 38538536 [TBL] [Abstract][Full Text] [Related]
8. Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair. Xu J; Zhu W; Xu W; Cui X; Chen L; Ji S; Qin Y; Yao W; Liu L; Liu C; Long J; Li M; Yu X Int J Oncol; 2013 Jun; 42(6):2046-52. PubMed ID: 23588667 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic Role of Heterogeneous Nuclear Ribonucleoprotein C in Multiple Cancer Types, with a Particular Focus on Lung Adenocarcinoma, Using a Pan-Cancer Analysis and Cell Line Experiments. Zhang L; Peng H; Jiang L J Environ Pathol Toxicol Oncol; 2022; 41(3):77-93. PubMed ID: 35993957 [TBL] [Abstract][Full Text] [Related]
10. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway. Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885 [TBL] [Abstract][Full Text] [Related]
11. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. Souchek JJ; Baine MJ; Lin C; Rachagani S; Gupta S; Kaur S; Lester K; Zheng D; Chen S; Smith L; Lazenby A; Johansson SL; Jain M; Batra SK Br J Cancer; 2014 Sep; 111(6):1139-49. PubMed ID: 25025965 [TBL] [Abstract][Full Text] [Related]
12. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer. Pranatharthi A; Thomas P; Udayashankar AH; Bhavani C; Suresh SB; Krishna S; Thatte J; Srikantia N; Ross CR; Srivastava S J Exp Clin Cancer Res; 2019 Sep; 38(1):392. PubMed ID: 31488179 [TBL] [Abstract][Full Text] [Related]
13. The m6A reader HNRNPC predicts adverse prognosis and promotes the progression of colorectal cancer. Yu YM; Hu Y Technol Health Care; 2024; 32(3):1445-1453. PubMed ID: 37661903 [TBL] [Abstract][Full Text] [Related]
14. HNRNPC as a candidate biomarker for chemoresistance in gastric cancer. Huang H; Han Y; Zhang C; Wu J; Feng J; Qu L; Shou C Tumour Biol; 2016 Mar; 37(3):3527-34. PubMed ID: 26453116 [TBL] [Abstract][Full Text] [Related]
15. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C. Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499 [TBL] [Abstract][Full Text] [Related]
16. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5. Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801 [TBL] [Abstract][Full Text] [Related]
17. A systematic pan-cancer study demonstrates the oncogenic function of heterogeneous nuclear ribonucleoprotein C. Pan C; Wu Q; Feng N Aging (Albany NY); 2022 Mar; 14(6):2880-2901. PubMed ID: 35344508 [TBL] [Abstract][Full Text] [Related]
18. Identification of genetic variants in m Ying P; Li Y; Yang N; Wang X; Wang H; He H; Li B; Peng X; Zou D; Zhu Y; Zhong R; Miao X; Tian J; Chang J Arch Toxicol; 2021 Mar; 95(3):1117-1128. PubMed ID: 33474615 [TBL] [Abstract][Full Text] [Related]
19. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner. Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359 [TBL] [Abstract][Full Text] [Related]
20. Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells. Chen XY; Wang Z; Li B; Zhang YJ; Li YY Biochem Biophys Res Commun; 2016 Apr; 473(1):296-302. PubMed ID: 27016481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]